Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-15 Sale | 2023-03-17 6:02 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer | 13,360 | $0.7816 | $10,442 | 265,891 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 7:59 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 13,305 | $1.0697 | $14,232 | 273,251 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 4:35 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 21,925 | $1.14 | $24,994 | 280,556 (Direct) | View |
| 2021-12-08 Purchase | 2021-12-10 5:26 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 25,000 | $1.91 | $47,750 | 258,631 (Direct) | View |
| 2020-08-17 Purchase | 2020-08-19 6:48 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer | 7,692 | $13 | $99,996 | 10,692 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-03 Option Award | 2024-03-12 7:06 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:27 pm | N/A 2034-02-11 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:22 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 6:59 pm | N/A 2032-09-13 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 394,771 | $0 | 394,771 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-17 4:51 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 255,000 | $0 | 255,000 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 9:24 pm | N/A 2031-08-05 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 380,000 | $0 | 390,692 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 9:05 pm | N/A 2031-02-15 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-21 7:18 pm | N/A 2030-02-19 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer | 40,750 | $0 | 40,750 (Direct) | View |
| 2019-10-30 Option Award | 2019-11-01 5:15 pm | N/A 2029-10-29 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2019-11-01 5:14 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer | 0 | $0 | 0 (Direct) | View |